These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 21939730

  • 61. Role of nuclear factor of activated T-cells 5 in regulating hypertonic-mediated secretin receptor expression in kidney collecting duct cells.
    Chua OW, Wong KK, Ko BC, Chung SK, Chow BK, Lee LT.
    Biochim Biophys Acta; 2016 Jul; 1859(7):922-32. PubMed ID: 27080132
    [Abstract] [Full Text] [Related]

  • 62. Metabolic effects of secretin.
    Sekar R, Chow BK.
    Gen Comp Endocrinol; 2013 Jan 15; 181():18-24. PubMed ID: 23246720
    [Abstract] [Full Text] [Related]

  • 63. Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping.
    Dong M, Xu X, Ball AM, Makhoul JA, Lam PC, Pinon DI, Orry A, Sexton PM, Abagyan R, Miller LJ.
    FASEB J; 2012 Dec 15; 26(12):5092-105. PubMed ID: 22964305
    [Abstract] [Full Text] [Related]

  • 64. Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls.
    Gilliam-Vigh H, Jorsal T, Nielsen SW, Forman JL, Pedersen J, Poulsen SS, Vilsbøll T, Knop FK.
    J Clin Endocrinol Metab; 2023 Nov 17; 108(12):e1597-e1602. PubMed ID: 37335970
    [Abstract] [Full Text] [Related]

  • 65. Role of N-linked glycosylation on the function and expression of the human secretin receptor.
    Pang RT, Ng SS, Cheng CH, Holtmann MH, Miller LJ, Chow BK.
    Endocrinology; 1999 Nov 17; 140(11):5102-11. PubMed ID: 10537138
    [Abstract] [Full Text] [Related]

  • 66. Real-time evaluation of human secretin receptor activity using cytosensor microphysiometry.
    Ng SS, Pang RT, Chow BK, Cheng CH.
    J Cell Biochem; 1999 Mar 15; 72(4):517-27. PubMed ID: 10022611
    [Abstract] [Full Text] [Related]

  • 67. Importance of each residue within secretin for receptor binding and biological activity.
    Dong M, Le A, Te JA, Pinon DI, Bordner AJ, Miller LJ.
    Biochemistry; 2011 Apr 12; 50(14):2983-93. PubMed ID: 21388146
    [Abstract] [Full Text] [Related]

  • 68. Identification and characterization of a motilin-like peptide and its receptor in teleost.
    Liu Y, Li S, Huang X, Lu D, Liu X, Ko WH, Zhang Y, Cheng CH, Lin H.
    Gen Comp Endocrinol; 2013 Jun 01; 186():85-93. PubMed ID: 23500008
    [Abstract] [Full Text] [Related]

  • 69. A novel secretin receptor splice variant potentially useful for early diagnosis of pancreatic carcinoma.
    Hayes GM, Carrigan PE, Dong M, Reubi JC, Miller LJ.
    Gastroenterology; 2007 Sep 01; 133(3):853-61. PubMed ID: 17678920
    [Abstract] [Full Text] [Related]

  • 70. Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system.
    Cheng CY, Chu JY, Chow BK.
    Neuropsychopharmacology; 2011 Jan 01; 36(2):459-71. PubMed ID: 20927047
    [Abstract] [Full Text] [Related]

  • 71. Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality.
    Di Paolo E, Vilardaga JP, Petry H, Moguilevsky N, Bollen A, Robberecht P, Waelbroeck M.
    Peptides; 1999 Jan 01; 20(10):1187-93. PubMed ID: 10573290
    [Abstract] [Full Text] [Related]

  • 72. Characterization of fibronectin type III domain-containing protein 5 (FNDC5) gene in chickens: Cloning, tissue expression, and regulation of its expression in the muscle by fasting and cold exposure.
    Li X, Fang W, Hu Y, Wang Y, Li J.
    Gene; 2015 Oct 10; 570(2):221-9. PubMed ID: 26072164
    [Abstract] [Full Text] [Related]

  • 73. Insights into the structure and molecular basis of ligand docking to the G protein-coupled secretin receptor using charge-modified amino-terminal agonist probes.
    Dong M, Pinon DI, Miller LJ.
    Mol Endocrinol; 2005 Jul 10; 19(7):1821-36. PubMed ID: 15731172
    [Abstract] [Full Text] [Related]

  • 74. Identification, spatial expression analysis and functional characterization of a pyrokinin-1 receptor in the Chagas' disease vector, Rhodnius prolixus.
    Paluzzi JP, O'Donnell MJ.
    Mol Cell Endocrinol; 2012 Nov 05; 363(1-2):36-45. PubMed ID: 22820129
    [Abstract] [Full Text] [Related]

  • 75. Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex.
    Lee LT, Ng SY, Chu JY, Sekar R, Harikumar KG, Miller LJ, Chow BK.
    FASEB J; 2014 Jun 05; 28(6):2632-44. PubMed ID: 24599969
    [Abstract] [Full Text] [Related]

  • 76. Secretin: structure of the precursor and tissue distribution of the mRNA.
    Kopin AS, Wheeler MB, Leiter AB.
    Proc Natl Acad Sci U S A; 1990 Mar 05; 87(6):2299-303. PubMed ID: 2315322
    [Abstract] [Full Text] [Related]

  • 77. In vivo actions of SCTR/AT1aR heteromer in controlling Vp expression and release via cFos/cAMP/CREB pathway in magnocellular neurons of PVN.
    Mak SOK, Zhang L, Chow BKC.
    FASEB J; 2019 Apr 05; 33(4):5389-5398. PubMed ID: 30702925
    [Abstract] [Full Text] [Related]

  • 78. Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma.
    Ding WQ, Kuntz S, Böhmig M, Wiedenmann B, Miller LJ.
    Gastroenterology; 2002 Feb 05; 122(2):500-11. PubMed ID: 11832464
    [Abstract] [Full Text] [Related]

  • 79. Molecular pharmacology of the secretin receptor.
    Dong M, Miller LJ.
    Recept Channels; 2002 Feb 05; 8(3-4):189-200. PubMed ID: 12529936
    [Abstract] [Full Text] [Related]

  • 80. Insignificant effect of secretin in rodent models of polycystic kidney and liver disease.
    Wang X, Ye H, Ward CJ, Chu JY, Masyuk TV, Larusso NF, Harris PC, Chow BK, Torres VE.
    Am J Physiol Renal Physiol; 2012 Oct 05; 303(7):F1089-98. PubMed ID: 22811488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.